Elevated extracellular matrix protein 1 in circulating extracellular vesicles supports breast cancer progression under obesity conditions

Nat Commun. 2024 Feb 24;15(1):1685. doi: 10.1038/s41467-024-45995-5.

Abstract

The cargo content in small extracellular vesicles (sEVs) changes under pathological conditions. Our data shows that in obesity, extracellular matrix protein 1 (ECM1) protein levels are significantly increased in circulating sEVs, which is dependent on integrin-β2. Knockdown of integrin-β2 does not affect cellular ECM1 protein levels but significantly reduces ECM1 protein levels in the sEVs released by these cells. In breast cancer (BC), overexpressing ECM1 increases matrix metalloproteinase 3 (MMP3) and S100A/B protein levels. Interestingly, sEVs purified from high-fat diet-induced obesity mice (D-sEVs) deliver more ECM1 protein to BC cells compared to sEVs from control diet-fed mice. Consequently, BC cells secrete more ECM1 protein, which promotes cancer cell invasion and migration. D-sEVs treatment also significantly enhances ECM1-mediated BC metastasis and growth in mouse models, as evidenced by the elevated tumor levels of MMP3 and S100A/B. Our study reveals a mechanism and suggests sEV-based strategies for treating obesity-associated BC.

MeSH terms

  • Animals
  • Extracellular Matrix Proteins / metabolism
  • Extracellular Vesicles* / metabolism
  • Integrins
  • Matrix Metalloproteinase 3 / genetics
  • Mice
  • Neoplasms*
  • Obesity

Substances

  • Extracellular Matrix Proteins
  • Integrins
  • Matrix Metalloproteinase 3
  • Ecm1 protein, mouse